Cargando…
Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway
BACKGROUND: The cisplatin-resistance is still a main course for chemotherapy failure of lung cancer patients. Cisplatin-resistant cancer cells own higher malignance and exhibited increased metastatic ability, but the mechanism is not clear. In this study, we investigated the effects of Ataxia Telang...
Autores principales: | Shen, Mingjing, Xu, Zhonghua, Xu, Weihua, Jiang, Kanqiu, Zhang, Fuquan, Ding, Qifeng, Xu, Zhonghen, Chen, Yongbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454747/ https://www.ncbi.nlm.nih.gov/pubmed/30961670 http://dx.doi.org/10.1186/s13046-019-1161-8 |
Ejemplares similares
-
Characterization of TCF‐1 and its relationship between CD8+ TIL densities and immune checkpoints and their joint influences on prognoses of lung adenocarcinoma patients
por: Jiang, Kanqiu, et al.
Publicado: (2023) -
ATM-JAK-PD-L1 signaling pathway inhibition decreases EMT and metastasis of androgen-independent prostate cancer
por: Zhang, Lan, et al.
Publicado: (2018) -
Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: in vitro/vivo evaluation
por: Jiang, Kanqiu, et al.
Publicado: (2018) -
Correction: MiR-940 inhibits TGF-β-induced epithelial-mesenchymal transition and cell invasion by targeting Snail in non-small cell lung cancer
por: Jiang, Kanqiu, et al.
Publicado: (2020) -
MiR-940 inhibits TGF-β-induced epithelial-mesenchymal transition and cell invasion by targeting Snail in non-small cell lung cancer
por: Jiang, Kanqiu, et al.
Publicado: (2019)